3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Meningioma
7
Brain Neoplasms
6
Leukemia, Myeloid, Acute
5
Head and Neck Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Neoplasms
3
Glioblastoma
3
Stomach Neoplasms
2
Myeloproliferative Disorders
2
Myelodysplastic Syndromes
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia
2
Laryngeal Neoplasms
2
Gliosarcoma
2
Esophageal Neoplasms
2
Central Nervous System Neoplasms
2
Thyroid Carcinoma, Anaplastic
1
Thrombocytosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pharyngeal Neoplasms
1
Paranasal Sinus Neoplasms
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Nose Neoplasms
1
Nasopharyngeal Neoplasms
1
Myelodysplastic-Myeloproliferative Diseases
1
Interventions
Cisplatin
39
Radiotherapy
21
Carboplatin
21
Cetuximab
20
Paclitaxel
19
Docetaxel
17
Radiotherapy, Intensity-Modulated
15
pembrolizumab
14
Fluorouracil
13
Drug Therapy
10
Nivolumab
8
Radiation
6
cemiplimab
5
atezolizumab
5
Panitumumab
5
Oxaliplatin
5
Erlotinib Hydrochloride
5
Chemoradiotherapy
5
Afatinib
5
Surgical Procedures, Operative
4
durvalumab
3
Surveys and Questionnaires
3
Methotrexate
3
Leucovorin
3
Lapatinib
3
130-nm albumin-bound paclitaxel
3
toripalimab
2
palbociclib
2
osimertinib
2
dacomitinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Carcinoma, Squamous Cell
×
Hydroxyurea
×
Clear all
NCT03944915
2025-05-11
DEPEND
University of Chicago
Phase 2
Completed
35 enrolled
14 charts